Steven J. Rice - Jun 25, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Administrative Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: Jun 25, 2021
Transactions value $: -$112
Form type: 4
Date filed: 6/29/2021, 05:12 PM
Next filing: Aug 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$38.30	+3	+0.02%	$12.76	20K	Jun 25, 2021	Direct
transaction	VIR	Common Stock	Sale	-$150	-3	-0.01%	$50.00	20K	Jun 25, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Employee Stock Option (Right to Buy)	Options Exercise	$0	-3	0%	$0.00	444K	Jun 25, 2021	Common Stock	3	$12.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F2	1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.